Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: A community-based survey

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  Hestvik, Elin ^a,b   Tumwine, James K ^c   Tylleskar, Thorkild ^a   Grahnquist, Lena ^d   Ndeezi, Grace ^a,c   Kaddu Mulindwa, Deogratias H ^c   Aksnes, Lage ^a,b   Olafsdottir, Edda ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CALGRANULIN; BIOLOGICAL MARKER;

ARTICLE; BACTERIAL GROWTH; BED NET; CAREGIVER; CHILD; DEMOGRAPHY; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GENDER; HEALTH STATUS; HELICOBACTER PYLORI; HELMINTH; HUMAN; HUMAN EXPERIMENT; INFANT; INTERVIEW; MALE; MEDICAL HISTORY; MICROSCOPY; NONHUMAN; NORMAL HUMAN; PRESCHOOL CHILD; PROTOZOON; SCHOOL CHILD; UGANDA; URBAN AREA; AGE; CHEMISTRY; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; ENTERITIS; IMMUNOLOGY; INTESTINE INFECTION; IRRITABLE COLON; METABOLISM; MICROBIOLOGY; NEWBORN; PARASITOLOGY; REFERENCE VALUE; SOCIOECONOMICS; URBAN POPULATION;

AGE FACTORS; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIAGNOSIS, DIFFERENTIAL; FECES; FEMALE; HELICOBACTER PYLORI; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES, PARASITIC; IRRITABLE BOWEL SYNDROME; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; REFERENCE VALUES; SOCIOECONOMIC FACTORS; UGANDA; URBAN POPULATION;

EID: 79251645950     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-9     Document Type: Article

References (40)

1. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scan J Haematol 1980, 24(1980):393-398.
2. Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985, 84(1):24-34.
3. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988, 72(3):510-515. 1541584, 3048809.
4. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992, 27(9):793-798. 10.3109/00365529209011186, 1411288.
5. Ton H, Brandsnes, Dale S, Holtlund J, Skuibina E, Schjonsby H, Johne B. Improved assay for fecal calprotectin. Clin Chim Acta 2000, 292(1-2):41-54. 10.1016/S0009-8981(99)00206-5, 10686275.
6. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997, 50(3):113-123. 10.1136/mp.50.3.113, 379605, 9292145.
7. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000, 47(4):506-513. 10.1136/gut.47.4.506, 1728060, 10986210.
8. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997, 58(2):176-180. 10.1159/000201441, 9144308.
9. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001, 32(2):171-177. 10.1097/00005176-200102000-00015, 11321388.
10. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002, 91(1):45-50. 10.1080/080352502753457932, 11883817.
11. Bunn S, Bisset M, Main M, Golden B. Faecal calprotectin as a marker of gastrointestinal inflammation during the first year of life (abstract). J Pediatr Gastroenterol Nutr 2000, 31(Suppl 2):43.
12. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol 2000, 35(1):64-69. 10.1080/003655200750024551, 10672837.
13. Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008, 14(1):32-39. 10.1002/ibd.20275, 17924558.
14. Hanevik K, Hausken T, Morken MH, Strand EA, Morch K, Coll P, Helgeland L, Langeland N. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect 2007, 55(6):524-530. 10.1016/j.jinf.2007.09.004, 17964658.
15. Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis 2008, 23(10):985-992. 10.1007/s00384-008-0506-0, 18629518.
16. Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004, 36(7):467-470. 10.1016/j.dld.2004.02.009, 15285526.
17. Roseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, Roald B. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?. Scand J Gastroenterol 1993, 28(12):1073-1076. 10.3109/00365529309098312, 8303210.
18. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999, 45(3):362-366. 10.1136/gut.45.3.362, 1727647, 10446103.
19. Savino F, Castagno E, Calabrese R, Viola S, Oggero R, Miniero R. High Faecal Calprotectin Levels in Healthy, Exclusively Breast-Fed Infants. Neonatology 2009, 97(4):299-304. 10.1159/000255161, 19887860.
20. Josefsson S, Bunn SK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007, 44(4):407-413. 10.1097/MPG.0b013e3180320643, 17414135.
21. Yang Q, Smith PB, Goldberg RN, Cotten CM. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008, 94(4):267-271. 10.1159/000151645, 2790758, 18784422.
22. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003, 37(4):468-472. 10.1097/00005176-200310000-00013, 14508218.
23. Betson M, Sousa-Figueiredo JC, Rowell C, Kabatereine NB, Stothard JR. Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity. Am J Trop Med Hyg 2010, 83(5):1048-1055. 10.4269/ajtmh.2010.10-0307, 2963968, 21036836.
24. Hestvik E, Tylleskar T, Kaddu-Mulindwa DH, Ndeezi G, Grahnquist L, Olafsdottir E, Tumwine JK. Helicobacter pylori in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based cross sectional survey. BMC Gastroenterol 2010, 10(1):62. 10.1186/1471-230X-10-62, 2901381, 20553588.
25. Asilsoy S, Babayigit A, Olmez D, Uzuner N, Karaman O, Oren O, Turgut CS, Tezcan D. Helicobacter Pylori Infection and Gastroesophageal Reflux in Asthmatic Children. J Trop Pediatr 2007,
26. Bremner A, Roked S, Robinson R, Phillips I, Beattie M. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 2005, 94(12):1855-1858. 10.1080/08035250500254639, 16421055.
27. Nissen AC, van Gils CE, Menheere PP, Van den Neucker AM, van der Hoeven MA, Forget PP. Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004, 38(1):107-108.
28. Pezzilli R, Barassi A, Morselli Labate AM, Finazzi S, Fantini L, Gizzi G, Lotzniker M, Villani V, Melzi d'Eril G, Corinaldesi R. Fecal calprotectin levels in patients with colonic polyposis. Dig Dis Sci 2008, 53(1):47-51. 10.1007/s10620-007-9820-6, 17468955.
29. Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa?. Am J Trop Med Hyg 1995, 53(1):36-39.
30. Goka AK, Rolston DD, Mathan VI, Farthing MJ. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg 1990, 84(1):66-67. 10.1016/0035-9203(90)90386-S, 2345928.
31. Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis 1997, 25(3):545-549. quiz 550, 10.1086/513745, 9314441.
32. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002, 16(Suppl 1):3-15. 10.1046/j.1365-2036.2002.0160s1003.x, 11849122.
33. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009, 15(11):971-976. 10.1111/j.1469-0691.2009.03031.x, 19874380.
34. Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002, 14(8):841-845. 10.1097/00042737-200208000-00005, 12172403.
35. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123(2):450-460. 10.1053/gast.2002.34755, 12145798.
36. Thia KT, Loftus EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008, 103(12):3167-3182. 10.1111/j.1572-0241.2008.02158.x, 19086963.
37. von Roon AC, Karamountzos L, Purkayastha S, Reese GE, Darzi AW, Teare JP, Paraskeva P, Tekkis PP. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007, 102(4):803-813. 10.1111/j.1572-0241.2007.01126.x, 17324124.
38. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12(6):524-534. 10.1097/00054725-200606000-00013, 16775498.
39. Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004, 89(4):F353-355. 10.1136/adc.2002.022368, 1721713, 15210674.
40. Dorosko SM, Mackenzie T, Connor RI. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed Med 2008, 3(2):117-119. 10.1089/bfm.2007.0036, 18564000.